Dr Reddys Laboratories (RDY) Property, Plant & Equipment (Net) (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Property, Plant & Equipment (Net) of $1.22 billion for the quarter ended Jun 30, 2026, up 1.6% from $1.2 billion a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Property, Plant & Equipment (Net) came in at $1.24 billion, up 8.0% from the prior year.
- Annual Property, Plant & Equipment (Net) has increased for three consecutive years, with a five-year compound annual growth rate of 9.6% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Property, Plant & Equipment (Net) was $1.14 billion in the year ended Mar 31, 2025 (+23.9%), $923 million in the year ended Mar 31, 2024 (+14.0%), $810 million in the year ended Mar 31, 2023 (-1.1%) and $819 million in the year ended Mar 31, 2022 (+4.9%).
- Quarterly Property, Plant & Equipment (Net) has run from a low of $778 million in the quarter ended Jun 30, 2022 to a high of $1.3 billion in the quarter ended Dec 31, 2025 over five years.
- On a year-over-year basis, Property, Plant & Equipment (Net) has increased in each of the last 13 quarters, with growth averaging 18.7% over the last eight quarters.
- The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was the quarter ended Dec 31, 2024, with growth of 26.1%; the weakest was the quarter ended Dec 31, 2022, with a decline of 5.8%.
- According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $1.27 billion (quarter ended Mar 31, 2026), $1.3 billion (quarter ended Dec 31, 2025) and $1.28 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 23.58 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 19.03 Bn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 1.22 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.30 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.13 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.04 Bn |
| Jun 30, 2024 | 963.13 Mn |
| Mar 31, 2024 | 925.83 Mn |
| Dec 31, 2023 | 874.26 Mn |
| Sep 30, 2023 | 852.57 Mn |
| Jun 30, 2023 | 819.00 Mn |
| Mar 31, 2023 | 808.50 Mn |
| Dec 31, 2022 | 791.65 Mn |
| Sep 30, 2022 | 800.44 Mn |
| Jun 30, 2022 | 778.00 Mn |
| Mar 31, 2022 | 826.79 Mn |
| Dec 31, 2021 | 840.45 Mn |
| Sep 30, 2021 | 812.86 Mn |
API Access
Dr Reddys Laboratories Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();